CN113913520A - 检测人类idh1基因r132h突变的探针法及其试剂盒 - Google Patents

检测人类idh1基因r132h突变的探针法及其试剂盒 Download PDF

Info

Publication number
CN113913520A
CN113913520A CN202111291316.7A CN202111291316A CN113913520A CN 113913520 A CN113913520 A CN 113913520A CN 202111291316 A CN202111291316 A CN 202111291316A CN 113913520 A CN113913520 A CN 113913520A
Authority
CN
China
Prior art keywords
mutation
value
idh1r132h
reaction system
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111291316.7A
Other languages
English (en)
Inventor
刘涛
王文
李文霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan Yongding Medical Technology Co ltd
Original Assignee
Wuhan Yongding Medical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Yongding Medical Technology Co ltd filed Critical Wuhan Yongding Medical Technology Co ltd
Priority to CN202111291316.7A priority Critical patent/CN113913520A/zh
Publication of CN113913520A publication Critical patent/CN113913520A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

本发明公开了检测人类IDH1基因R132H突变的探针法及其试剂盒,本发明涉及生物医疗技术领域,检测人类IDH1基因R132H突变的探针法,包括以下步骤:(1)在IDH1R132HPCR反应混合液中加入人类基因组DNA,形成R132H反应体系并进行荧光定量PCR扩增;(2)结果判断:根据PCR扩增的突变Ct值进行分析;IDH1R132H反应混合液中包括:具有如序列表中SEQIDNo.3所示序列的IDH1R132H前向引物、具有如序列表中SEQIDNo.4所示序列的IDH1R132H反向引物和含有荧光染料的PCR预混液;本发明的有益效果在于:该探针法和试剂盒为临床提供了一种实现对IDH1基因R132H突变的高灵敏度检测,并且IDH1基因R132H突变的检测速度快、效率高、特异性强。

Description

检测人类IDH1基因R132H突变的探针法及其试剂盒
技术领域
本发明涉及生物医疗技术领域,尤其是涉及检测人类IDH1基因R132H突变的探针法及其试剂盒。
背景技术
异柠檬酸脱氢酶(IDH)家族包括以NAD或NADP为辅助因子,催化异柠檬酸的氧化脱羧反应生成α-酮戊二酸的酶类,同时分别生成NADH或NADPH。在哺乳动物细胞中, IDH同工酶有以下三种形式:依赖NAD的线粒体IDH1,依赖NADP的线粒体IDH2,依 赖NADP的胞质IDH3。编码依赖NAD的人IDH1的IDH1基因位于染色体2q33.3,并且 定位于细胞质和过氧化物酶体中;编码依赖NADP的线粒体IDH2酶的IDH2基因位于 染色体15q26.1,但是现在检测人类IDH1基因R132H突变的探针法的灵敏度检测率比较低,并且速度慢同时其特异性不强。
发明内容
本发明旨在克服上述现有技术的至少缺陷,提供检测人类IDH1基因R132H突变的探针法,包括以下步骤:
(1)在IDH1R132HPCR反应混合液中加入人类基因组DNA,形成R132H反应体系并进行荧光定量PCR扩增;
(2)结果判断:根据PCR扩增的突变Ct值进行分析。
作为优选的,所述IDH1R132H反应混合液中包括:具有如序列表中SEQIDNo.3所示序列的IDH1R132H前向引物、具有如序列表中SEQIDNo.4所示序列的IDH1R132H反向引物和含有荧光染料的PCR预混液。
作为优选的,所述在IDH1R132H反应混合液中加入人类基因组DNA:在10μLIDH1R132H反应混合液中加入4.5μL、浓度为9ng/μL的人类基因组DNA,其中:在IDH1R132H反应混合液中IDH1R132H前向引物、IDH1R132H反向引物和含有荧光染料的3×PCR预混液的体积比为(1.5-2):(1.5-2):(7.5-8),优选为1.55:1.55:8;在IDH1R132H反应混合液中IDH1R132H前向引物和IDH1R132H反向引物的浓度均为2-8μM,优选3-4μM,更优选4.5μM。
作为优选的,所述荧光定量PCR方法的扩增过程为:(1)95℃、4min、循环数为1;(2)95℃、18s,68℃、20s,循环数为18;(3)95℃、15s,57.6℃、20s,循环数为26;(4)升温至98℃。
本发明提供根据以上所述的检测人类EGFR基因L858R突变的检测方法,所述对Ct值进行分析的步骤为:
当样品在R132H反应体系的突变Ct值大于或等于阴性临界值19时,则该样品的R132H突变为阴性或小于本试剂盒的检测最低阈值;
当样品在R132H反应体系的突变Ct值小于阴性临界值19时,按照以下标准进行判断:当该样品在R132H反应体系的突变Ct值小于或等于阳性临界值16时,则该样品的R132H突变为阳性,即强阳;当该样品在R132H反应体系的突变Ct值大于阳性临界值16时,则计算R132H反应体系的△Ct,ΔCt值=R132H反应体系突变Ct值-该样本在内标反应体系的Ct值,若反应体系的△Ct值小于相应的△CtCut-off值9,则该样品的R132H突变也为阳性,即弱阳,若反应体系的△Ct值大于或等于相应的△CtCut-off值9,则该样品的R132H突变为阴性或低于本试剂盒的检测最低阈值。
采用上述技术方案,所取得的有益效果是:
该探针法和试剂盒为临床提供了一种实现对IDH1基因R132H突变的高灵敏度检测,并且IDH1基因R132H突变的检测速度快、效率高、特异性强。
具体实施方式
为使本发明的目的、技术方案及优点更加清楚明白,以下结合具体实施方式,对本发明进行进一步的详细说明。应当理解的是,此处所描述的具体实施方式仅用以解释本发明,并不限定本发明的保护范围。
本申请是检测人类IDH1基因R132H突变的探针法及其试剂盒,所述检测人类IDH1基因R132H突变的探针法,包括以下步骤:
(1)在IDH1R132HPCR反应混合液中加入人类基因组DNA,形成R132H反应体系并进行荧光定量PCR扩增,所述IDH1R132H反应混合液中包括:具有如序列表中SEQIDNo.3所示序列的IDH1R132H前向引物、具有如序列表中SEQIDNo.4所示序列的IDH1R132H反向引物和含有荧光染料的PCR预混液,所述在IDH1R132H反应混合液中加入人类基因组DNA:在10μLIDH1R132H反应混合液中加入4.5μL、浓度为9ng/μL的人类基因组DNA,其中:在IDH1R132H反应混合液中IDH1R132H前向引物、IDH1R132H反向引物和含有荧光染料的3×PCR预混液的体积比为(1.5-2):(1.5-2):(7.5-8),优选为1.55:1.55:8;在IDH1R132H反应混合液中IDH1R132H前向引物和IDH1R132H反向引物的浓度均为2-8μM,优选3-4μM,更优选4.5μM,所述荧光定量PCR方法的扩增过程为:(1)95℃、4min、循环数为1;(2)95℃、18s,68℃、20s,循环数为18;(3)95℃、15s,57.6℃、20s,循环数为26;(4)升温至98℃;
(2)结果判断:根据PCR扩增的突变Ct值进行分析。
本发明提供根据以上所述的检测人类EGFR基因L858R突变的检测方法,所述对Ct值进行分析的步骤为:
当样品在R132H反应体系的突变Ct值大于或等于阴性临界值19时,则该样品的R132H突变为阴性或小于本试剂盒的检测最低阈值;
当样品在R132H反应体系的突变Ct值小于阴性临界值19时,按照以下标准进行判断:当该样品在R132H反应体系的突变Ct值小于或等于阳性临界值16时,则该样品的R132H突变为阳性,即强阳;当该样品在R132H反应体系的突变Ct值大于阳性临界值16时,则计算R132H反应体系的△Ct,ΔCt值=R132H反应体系突变Ct值-该样本在内标反应体系的Ct值,若反应体系的△Ct值小于相应的△CtCut-off值9,则该样品的R132H突变也为阳性,即弱阳,若反应体系的△Ct值大于或等于相应的△CtCut-off值9,则该样品的R132H突变为阴性或低于本试剂盒的检测最低阈值。

Claims (5)

1.检测人类IDH1基因R132H突变的探针法,其特征在于,包括以下步骤:
(1)在IDH1R132HPCR反应混合液中加入人类基因组DNA,形成R132H反应体系并进行荧光定量PCR扩增;
(2)结果判断:根据PCR扩增的突变Ct值进行分析。
2.根据权利要求1所述的检测人类IDH1基因R132H突变的试剂盒,其特征在于:所述IDH1R132H反应混合液中包括:具有如序列表中SEQIDNo.3所示序列的IDH1R132H前向引物、具有如序列表中SEQIDNo.4所示序列的IDH1R132H反向引物和含有荧光染料的PCR预混液。
3.根据权利要求1所述的检测人类IDH1基因R132H突变的试剂盒,其特征在于:所述在IDH1R132H反应混合液中加入人类基因组DNA:在10μLIDH1R132H反应混合液中加入4.5μL、浓度为9ng/μL的人类基因组DNA,其中:在IDH1R132H反应混合液中IDH1R132H前向引物、IDH1R132H反向引物和含有荧光染料的3×PCR预混液的体积比为(1.5-2):(1.5-2):(7.5-8),优选为1.55:1.55:8;在IDH1R132H反应混合液中IDH1R132H前向引物和IDH1R132H反向引物的浓度均为2-8μM,优选3-4μM,更优选4.5μM。
4.根据权利要求3所述的检测人类IDH1基因R132H突变的试剂盒,其特征在于:所述荧光定量PCR方法的扩增过程为:(1)95℃、4min、循环数为1;(2)95℃、18s,68℃、20s,循环数为18;(3)95℃、15s,57.6℃、20s,循环数为26;(4)升温至98℃。
5.权利要求4所述的检测人类EGFR基因L858R突变的检测方法,其特征在于,所述对Ct值进行分析的步骤为:
当样品在R132H反应体系的突变Ct值大于或等于阴性临界值19时,则该样品的R132H突变为阴性或小于本试剂盒的检测最低阈值;
当样品在R132H反应体系的突变Ct值小于阴性临界值19时,按照以下标准进行判断:当该样品在R132H反应体系的突变Ct值小于或等于阳性临界值16时,则该样品的R132H突变为阳性,即强阳;当该样品在R132H反应体系的突变Ct值大于阳性临界值16时,则计算R132H反应体系的△Ct,ΔCt值=R132H反应体系突变Ct值-该样本在内标反应体系的Ct值,若反应体系的△Ct值小于相应的△CtCut-off值9,则该样品的R132H突变也为阳性,即弱阳,若反应体系的△Ct值大于或等于相应的△CtCut-off值9,则该样品的R132H突变为阴性或低于本试剂盒的检测最低阈值。
CN202111291316.7A 2021-11-03 2021-11-03 检测人类idh1基因r132h突变的探针法及其试剂盒 Pending CN113913520A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111291316.7A CN113913520A (zh) 2021-11-03 2021-11-03 检测人类idh1基因r132h突变的探针法及其试剂盒

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111291316.7A CN113913520A (zh) 2021-11-03 2021-11-03 检测人类idh1基因r132h突变的探针法及其试剂盒

Publications (1)

Publication Number Publication Date
CN113913520A true CN113913520A (zh) 2022-01-11

Family

ID=79245231

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111291316.7A Pending CN113913520A (zh) 2021-11-03 2021-11-03 检测人类idh1基因r132h突变的探针法及其试剂盒

Country Status (1)

Country Link
CN (1) CN113913520A (zh)

Similar Documents

Publication Publication Date Title
Girbal et al. How neutral red modified carbon and electron flow in Clostridium acetobutylicum grown in chemostat culture at neutral pH
Bertsch et al. A novel route for ethanol oxidation in the acetogenic bacterium Acetobacterium woodii: the acetaldehyde/ethanol dehydrogenase pathway
Vasconcelos et al. Regulation of carbon and electron flow in Clostridium acetobutylicum grown in chemostat culture at neutral pH on mixtures of glucose and glycerol
Kim et al. Dihydrolipoamide dehydrogenase mutation alters the NADH sensitivity of pyruvate dehydrogenase complex of Escherichia coli K-12
CN109182501B (zh) 一种叶酸代谢基因多态性检测引物及试剂盒
Bryant et al. Purification and properties of primary and secondary alcohol dehydrogenases from Thermoanaerobacter ethanolicus
US20150267178A1 (en) Protein having flavin adenine dinucleotide-dependent glucose dehydrogenase activity
CN110283899B (zh) 一种检测人mthfr和mtrr基因突变的引物、探针及其试剂盒
Röhlen et al. Toward a hybrid biosensor system for analysis of organic and volatile fatty acids in fermentation processes
Lamed et al. Thermostable, ammonium-activated malic enzyme of Clostridium thermocellum
JP2010035448A (ja) 基質特異性が向上したフラビンアデニン依存性グルコースデヒドロゲナーゼ改変体
CN103525911A (zh) 利用高分辨熔解曲线分析技术检测华法林个体化用药相关基因多态性的方法
JP4979822B2 (ja) L−スレオニンの分析方法およびl−スレオニン脱水素酵素
EP1378575A1 (en) Method of detecting inorganic phosphoric acid, pyrophosphoric acid and nucleic acid and method of typing snp sequence of dna
CN105331589A (zh) 可再生辅酶nad+的水型nadh氧化酶及其编码基因与应用
CN109554376B (zh) 一种碱性尿酸氧化酶及其在检测试剂盒和降低食品中尿酸的应用
JP6460513B2 (ja) フラビンアデニンジヌクレオチド依存型グルコース脱水素酵素活性を有するタンパク質
CN111705131A (zh) 一种检测人idh1或idh2基因突变的pcr试剂盒
CN113913520A (zh) 检测人类idh1基因r132h突变的探针法及其试剂盒
CN104745544B (zh) 一种d‑乳酸氧化酶及其在d‑乳酸检测中的应用
CN109355369B (zh) 用于检测酒精代谢基因多态性的引物组、试剂盒及其应用
Frolov et al. Capacity of Azospirillum thiophilum for lithotrophic growth coupled to oxidation of reduced sulfur compounds
JP2017063786A (ja) L−キヌレニンの測定方法及び測定キット
Van Ophem et al. Different types of formaldehyde-oxidizing dehydrogenases in Nocardia species 239: purification and characterization of an NAD-dependent aldehyde dehydrogenase
CN1800852B (zh) 一种改进速率法检测临床诊断试剂

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication